rs151087704

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001080516.2(GRXCR2):​c.220C>G​(p.Gln74Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000786 in 1,613,828 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00090 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00077 ( 2 hom. )

Consequence

GRXCR2
NM_001080516.2 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 1.05

Publications

4 publications found
Variant links:
Genes affected
GRXCR2 (HGNC:33862): (glutaredoxin and cysteine rich domain containing 2) This gene encodes a protein containing a glutaredoxin domain, which functions in protein S-glutathionylation. A mutation in this gene was found in a family with autoosomal recessive nonsyndromic sensorineural deafness-101. [provided by RefSeq, Jun 2014]
GRXCR2 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 101
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003718257).
BP6
Variant 5-145872749-G-C is Benign according to our data. Variant chr5-145872749-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 377112.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRXCR2NM_001080516.2 linkc.220C>G p.Gln74Glu missense_variant Exon 1 of 3 ENST00000377976.3 NP_001073985.1 A6NFK2
GRXCR2XM_017009708.2 linkc.49-6021C>G intron_variant Intron 1 of 2 XP_016865197.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRXCR2ENST00000377976.3 linkc.220C>G p.Gln74Glu missense_variant Exon 1 of 3 2 NM_001080516.2 ENSP00000367214.1 A6NFK2
GRXCR2ENST00000639411.1 linkc.-69-6021C>G intron_variant Intron 2 of 3 5 ENSP00000491860.1 A0A1W2PQQ7

Frequencies

GnomAD3 genomes
AF:
0.000900
AC:
137
AN:
152170
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00308
Gnomad ASJ
AF:
0.00577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000911
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00105
AC:
263
AN:
251310
AF XY:
0.00108
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00116
Gnomad ASJ exome
AF:
0.00566
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000508
Gnomad NFE exome
AF:
0.00109
Gnomad OTH exome
AF:
0.00180
GnomAD4 exome
AF:
0.000774
AC:
1131
AN:
1461540
Hom.:
2
Cov.:
32
AF XY:
0.000810
AC XY:
589
AN XY:
727098
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33474
American (AMR)
AF:
0.00123
AC:
55
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00624
AC:
163
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000487
AC:
42
AN:
86250
European-Finnish (FIN)
AF:
0.000693
AC:
37
AN:
53420
Middle Eastern (MID)
AF:
0.00243
AC:
14
AN:
5768
European-Non Finnish (NFE)
AF:
0.000676
AC:
751
AN:
1111680
Other (OTH)
AF:
0.00114
AC:
69
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
69
137
206
274
343
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000900
AC:
137
AN:
152288
Hom.:
0
Cov.:
32
AF XY:
0.000994
AC XY:
74
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41556
American (AMR)
AF:
0.00307
AC:
47
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00577
AC:
20
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.000377
AC:
4
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000911
AC:
62
AN:
68032
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00123
Hom.:
0
Bravo
AF:
0.00105
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00128
AC:
11
ExAC
AF:
0.00121
AC:
147
EpiCase
AF:
0.00164
EpiControl
AF:
0.00184

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Dec 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 25, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

GRXCR2-related disorder Benign:1
Jul 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
7.0
DANN
Benign
0.13
DEOGEN2
Benign
0.0012
T
Eigen
Benign
-0.90
Eigen_PC
Benign
-0.87
FATHMM_MKL
Benign
0.42
N
LIST_S2
Benign
0.47
T
MetaRNN
Benign
0.0037
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.4
L
PhyloP100
1.1
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.40
N
REVEL
Benign
0.084
Sift
Benign
0.34
T
Sift4G
Benign
1.0
T
Polyphen
0.0090
B
MVP
0.040
MPC
0.017
ClinPred
0.032
T
GERP RS
2.7
PromoterAI
-0.00030
Neutral
Varity_R
0.055
gMVP
0.20
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151087704; hg19: chr5-145252312; API